Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
| ▸ | ACACA | Q13085 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1142628 | 0.83 | PRKCA (0.41) | PRKCAELANE | |
| SCHEMBL14700435 | 0.82 | PRKCA (0.53) | PRKCAELANE | |
| SCHEMBL7474619 | 0.79 | PRKCA (0.47) | PRKCAELANE | |
| SCHEMBL25380718 | 0.78 | PRKCA (0.46) | PRKCA | |
| SCHEMBL25380720 | 0.78 | PRKCA (0.46) | PRKCA | |
| Ammonia Solution, Strong SCHEMBL28509183 | 0.76 | PRKCA (0.42) | PRKCAELANE | |
| SCHEMBL10977945 | 0.75 | — | — | |
| SCHEMBL3068283 | 0.74 | THRB (0.41) | THRB | |
| SCHEMBL27906457 | 0.74 | PRKCA (0.42) | PRKCAELANE | |
| SCHEMBL11595235 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180125986-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | SATYAM APPARAO (IN) | 2018-05-10 | — | — | US | claimed |
| US-9714560-B2 | Protected scale inhibitors and methods relating thereto | HALLIBURTON ENERGY SERVICES, INC. (US) | 2017-07-25 | — | — | US | claimed |
| US-20150328323-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | SATYAM APPARAO (IN) | 2015-11-19 | — | — | US | claimed |
| WO-2014111957-A1 | NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS | SATYAM APPARAO (IN) | 2014-07-24 | — | — | WO | claimed |
| US-20220220134-A1 | PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2022-07-14 | — | — | US | disclosed |
| US-10351581-B2 | Phosphohistidine mimetics and antibodies to same | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2019-07-16 | — | — | US | disclosed |
| US-20190092796-A1 | PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2019-03-28 | — | — | US | disclosed |
| US-20180125986-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | SATYAM APPARAO (IN) | 2018-05-10 | — | — | US | disclosed |
| US-9844599-B2 | Nitric oxide releasing produgs of therapeutic agents | SATYAM APPARAO (IN) | 2017-12-19 | — | — | US | disclosed |
| US-9765154-B2 | Phosphohistidine analogs | THE ROCKEFELLER UNIVERSITY (US) | 2017-09-19 | — | — | US | disclosed |
| US-9714560-B2 | Protected scale inhibitors and methods relating thereto | HALLIBURTON ENERGY SERVICES, INC. (US) | 2017-07-25 | — | — | US | disclosed |
| US-20160311838-A1 | PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME | THE TRUSTEES OF PRINCETON UNIVERSITY | 2016-10-27 | — | — | US | disclosed |
| US-20150328323-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | SATYAM APPARAO (IN) | 2015-11-19 | — | — | US | disclosed |
| US-9035068-B2 | Phosphohistidine analogs | THE ROCKEFELLER UNIVERSITY (US) | 2015-05-19 | — | — | US | disclosed |
| WO-2015051079-A2 | PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2015-04-09 | — | — | WO | disclosed |
| WO-2014200757-A1 | PROTECTED SCALE INHIBITORS AND METHODS RELATING THERETO | HALLIBURTON ENERGY SERVICES, INC. (US) | 2014-12-18 | — | — | WO | disclosed |
| US-20140367101-A1 | Protected Scale Inhibitors and Methods Relating Thereto | HALLIBURTON ENERGY SERVICES, INC. | 2014-12-18 | — | — | US | disclosed |
| WO-2014111957-A1 | NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS | SATYAM APPARAO (IN) | 2014-07-24 | — | — | WO | disclosed |
| US-20130260398-A1 | PHOSPHOHISTIDINE ANALOGS | THE ROCKEFELLER UNIVERSITY (US) | 2013-10-03 | — | — | US | disclosed |
| US-20020198125-A1 | Water soluble package and liquid contents thereof | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190092796-A1 | PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME | PHPT1, CD4, CD81 | PRKCA 1859/4885THRB 3254/4885ELANE 4093/4885 |
| US-20130260398-A1 | PHOSPHOHISTIDINE ANALOGS | PHPT1, PTMS, CHAMP1 | PRKCA 1647/4885THRB 1136/4885ELANE 3685/4885 |
| US-20180125986-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | NOS2, NOS1, NOS3 | PRKCA 1223/4885THRB 2315/4885ELANE 411/4885 |
| US-20160311838-A1 | PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME | PHPT1, CD4, HCLS1 | PRKCA 1129/4885THRB 3409/4885ELANE 4434/4885 |
| US-20150328323-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | NOS2, NOS1, PTGIS | PRKCA 1285/4885THRB 2436/4885ELANE 416/4885 |
| US-20220220134-A1 | PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME | PHPT1, CD4, CD81 | PRKCA 1859/4885THRB 3254/4885ELANE 4093/4885 |
| US-10351581-B2 | Phosphohistidine mimetics and antibodies to same | PHPT1, CD4, HCLS1 | PRKCA 1129/4885THRB 3409/4885ELANE 4434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.